Planned Strategic Transaction for Enterprise
Apps Business Line Valued at $69
Million Progressing
Conference Call to be Held Today at
4:30 p.m. Eastern Time
PALO
ALTO, Calif., Nov. 14,
2022 /PRNewswire/ -- Inpixon® (Nasdaq: INPX), the
Indoor Intelligence® company, today provided a business update and
reported its financial results for the third quarter ended
September 30, 2022.

"We took a number of actions in the third quarter in furtherance
of our objective to unlock value for our shareholders," commented
Nadir Ali, CEO of Inpixon. "We
implemented initiatives to streamline our operations and reduce our
operating costs. We also signed a definitive agreement for the
spinoff and sale of our enterprise apps business segment with KINS
Technology Group Inc. in a transaction valued at approximately
$69 million, which we believe is a
significant win for our shareholders. We continue to see strong
demand for expansions within our existing customer base across both
business lines within our Indoor Intelligence segment. Although
overall macroeconomic market conditions have resulted in some
challenges, we still achieved revenue growth of approximately 30%
for the nine months ended September 30,
2022 compared to the same period last year. We believe the
activities we are undertaking will have a meaningful impact in
accelerating the path to profitability and positioning our Indoor
Intelligence business lines for continued growth and long-term
success."
Financial Results
Revenues for the three and nine months ended September 30, 2022 were $4.2 million and $14.1
million, respectively, compared to $4.5 million and $10.9
million for the comparable periods in the prior year for a
decrease of approximately 6% and an increase of approximately 30%,
respectively. This decrease during the third quarter of 2022 is
primarily attributable to delayed shipments in the IIoT product
line of our Indoor Intelligence segment and lower sales for the
SAVES product line. The increase in sales for the nine-month
period, is primarily attributable to the addition of the CXApp
product line in our Indoor Intelligence segment during the second
quarter of 2021 and the addition of the Intranav product line in
the fourth quarter of 2021. Gross profit for the three and nine
months ended September 30, 2022 was
$2.9 million and $10.1 million, respectively, compared to
$3.3 million and $7.9 million for the 2021 respective periods,
representing a decrease of approximately 10% and an increase of
28%, respectively. The gross profit margin for the three and nine
months ended September 30, 2022, was
70% and 71%, compared to 73% and 73% for the three and nine months
ended September 30, 2021,
respectively. This decrease in margin is primarily due to the sales
mix during the periods.
Net loss attributable to stockholders of Inpixon for the three
and nine months ended September 30,
2022 was $17.6 million and
$48.7 million, respectively, compared
to $33.6 million and $31.4 million, respectively, for the comparable
periods in the prior year. This increase in loss was primarily
attributable lower gross profit, a $7.6
million goodwill impairment and other non-cash items
including an unrealized net loss on equity securities, offset by
decreased operating expenses in the nine months ended September 30, 2022.
Non-GAAP Adjusted EBITDA for the three and nine months ended
September 30, 2022, was a loss of
$8.2 million and $26.9 million, respectively, compared to a loss
of $6.7 million and $18.5 million for the prior year periods,
respectively. Non-GAAP Adjusted EBITDA is defined as net income or
loss before interest, provision for income taxes, depreciation and
amortization plus adjustments for other income or expense items,
non-recurring items and non-cash items including stock-based
compensation.
Proforma non-GAAP net loss per basic and diluted common share
for the three and nine months ended September 30, 2022 was a loss of $3.96 and $13.44,
respectively, compared to a loss of $3.77 and $13.68
for the prior year periods. Non-GAAP net loss per share is defined
as net loss per basic and diluted share adjusted for non-cash items
including stock-based compensation, amortization of intangibles and
one-time charges and other adjustments including impairment of
goodwill, provision for valuation allowance on notes, and
acquisition costs.
Conference Call
Inpixon management will host a conference call today at
4:30 PM Eastern Time to discuss the
company's financial results for the 2022 third quarter ended
September 30, 2022, as well as review
the company's corporate progress and other developments.
The conference call will be available via telephone by dialing
toll-free 844-407-9500 for U.S. callers or +1 862-298-0850 for
international callers and entering access code Inpixon. A webcast
of the call may be accessed at
https://www.webcaster4.com/Webcast/Page/2235/47060 or on the
company's Investor Relations section of the website,
ir.inpixon.com.
Investors and other interested parties are invited to submit
questions to management prior to the call's start via email to
inpx@crescendo-ir.com.
A webcast replay will be available on the company's Investor
Relations section of the website (ir.inpixon.com) through
November 10, 2023. A telephone replay
of the call will be available approximately one hour following the
call, through November 17, 2022, and
can be accessed by dialing 877-481-4010 for U.S. callers or +1
919-882-2331 for international callers and entering access code
47060.
About Inpixon
Inpixon® (Nasdaq: INPX) is the innovator of Indoor
Intelligence®, delivering actionable insights for people, places
and things. Combining the power of mapping, positioning and
analytics, Inpixon helps to create smarter, safer, and more secure
environments. The company's Indoor Intelligence and mobile app
solutions are leveraged by a multitude of industries to optimize
operations, increase productivity, and enhance safety. Inpixon
customers can take advantage of industry leading location
awareness, RTLS, workplace and hybrid event solutions, analytics,
sensor fusion, IIoT and the IoT to create exceptional experiences
and to do good with indoor data. For the latest insights, follow
Inpixon on LinkedIn, Twitter, and
visit inpixon.com.
Non-GAAP Financial Measures
Management believes that certain financial measures not in
accordance with generally accepted accounting principles in
the United States ("GAAP") are
useful measures of operations. EBIDTA, Adjusted EBITDA and pro
forma net loss per share are non-GAAP measures. Inpixon defines
"EBITDA" as net income (loss) before interest, provision for
(benefit from) income taxes, and depreciation and amortization.
Management uses Adjusted EBITDA as a metric for which it manages
the business, and Inpixon defines "Adjusted EBITDA" as EBITDA plus
adjustments for other income or expense items, non-recurring items
and non-cash items. Inpixon defines "pro forma net loss per share"
as GAAP net loss per share adjusted for stock-based compensation,
amortization of intangibles and one-time charges including
impairment of goodwill and provision for valuation allowances.
Management provides Adjusted EBITDA and pro forma net loss per
share measures so that investors will have the same financial
information that management uses, which may assist investors in
assessing Inpixon's performance on a period-over-period basis.
Adjusted EBITDA or pro forma net loss per share is not a measure of
financial performance under GAAP, and should not be considered an
alternative to net income (loss) or any other measure of
performance under GAAP, or to cash flows from operating, investing
or financing activities as an indicator of cash flows or as a
measure of liquidity. Adjusted EBITDA and pro forma net loss per
share have limitations as analytical tools and should not be
considered either in isolation or as a substitute for analysis of
Inpixon's results as reported under GAAP.
For more information on our non-GAAP financial measures and a
reconciliation of GAAP to non-GAAP measures, please see the
"Reconciliation of Non-GAAP Financial Measures" table accompanying
this press release.
Important Information and Where to Find It
In connection with the proposed business combination of
Inpixon's enterprise apps business segment, which will be held by
CXApp Holding Corp. ("CXApp"), with KINS (the "Business
Combination") and the distribution of CXApp common stock to Inpixon
securityholders, CXApp has filed with the SEC a registration
statement on Form S-1 (the "Form S-1"), which includes a
preliminary prospectus registering shares of CXApp common stock and
KINS has filed with the SEC a registration statement on Form S-4
(the "Form S-4"), which includes a preliminary proxy
statement/prospectus in connection with the KINS stockholder vote
required in connection with the Business Combination and the
registration of shares of KINS common stock, warrants and certain
equity awards. This communication does not contain all the
information that should be considered concerning the Business
Combination. The final prospectus filed by CXApp will include the
final proxy statement/prospectus filed by KINS, which will serve as
an information statement/prospectus in connection with the spin-off
of CXApp. This communication is not a substitute for the
registration statements that CXApp and KINS will file with the SEC
or any other documents that KINS or CXApp may file with the SEC, or
that KINS, Inpixon or CXApp may send to stockholders in connection
with the Business Combination. It is not intended to form the basis
of any investment decision or any other decision in respect to the
Business Combination. KINS's stockholders and Inpixon's
stockholders and other interested persons are advised to read, when
available, the preliminary and definitive registration statements,
and documents incorporated by reference therein, as these materials
will contain important information about KINS, CXApp and the
Business Combination. The final proxy statement/prospectus
contained in KINS's registration statement will be mailed to KINS's
stockholders as of a record date to be established for voting on
the Business Combination.
The registration statements, proxy statement/prospectus and
other documents (when they are available) will also be available
free of charge, at the SEC's website at www.sec.gov, or by
directing a request to: KINS Technology Group, Inc., Four Palo Alto
Square, Suite 200, 3000 El Camino Real, Palo Alto, CA 94306.
Participants in the Solicitation
Inpixon, KINS and CXApp, and each of their respective directors,
executive officers and other members of their management and
employees may be deemed to be participants in the solicitation of
proxies from KINS's stockholders in connection with the Business
Combination. Stockholders are urged to carefully read the proxy
statement/prospectus regarding the Business Combination when it
becomes available, because it will contain important information.
Information regarding the persons who may, under the rules of the
SEC, be deemed participants in the solicitation of KINS's
stockholders in connection with the Business Combination will be
set forth in the registration statement when it is filed with the
SEC. Information about KINS's executive officers and directors and
CXApp's management and directors also will be set forth in the
registration statement relating to the Business Combination when it
becomes available.
No Solicitation or Offer
This communication shall neither constitute an offer to sell nor
the solicitation of an offer to buy any securities, or the
solicitation of any proxy, vote, consent or approval in any
jurisdiction in connection with the Business Combination, nor shall
there be any sale of securities in any jurisdiction in which the
offer, solicitation or sale would be unlawful prior to any
registration or qualification under the securities laws of any such
jurisdictions. This communication is restricted by law; it is not
intended for distribution to, or use by any person in, any
jurisdiction where such distribution or use would be contrary to
local law or regulation.
Forward-Looking Statements
This communication contains forward-looking statements. The
words "anticipate," "believe," "continue," "could," "estimate,"
"expect," "intend," "may," "might," "plan," "possible,"
"potential," "predict," "project," "should," "would" and similar
expressions may identify forward-looking statements, but the
absence of these words does not mean that a statement is not
forward-looking. All statements other than statements of historical
facts contained in this communication, including statements
regarding the expected timing and structure of the Business
Combination, the ability of the parties to complete the Business
Combination, the expected benefits of the Business Combination,
CXApp's future results of operations and financial position,
business strategy and its expectations regarding the application
of, and the rate and degree of market acceptance of, the CXApp
technology platform and other technologies, and Inpixon's
expectations regarding the remainder of its industrial IoT business
are forward-looking statements. These forward-looking statements
are not guarantees of future performance, conditions or results,
and involve a number of known and unknown risks, uncertainties,
assumptions and other important factors, many of which are outside
the control of Inpixon, CXApp and KINS, that could cause actual
results or outcomes to differ materially from those discussed in
the forward-looking statements. Important factors, among others,
that may affect actual results or outcomes include, but are not
limited to: the risk that the transactions may not be completed in
a timely manner or at all, which may adversely affect the price of
Inpixon's or KINS's securities; the risk that KINS stockholder
approval of the Business Combination is not obtained; the inability
to recognize the anticipated benefits of the Business Combination,
which may be affected by, among other things, the amount of funds
available in KINS's trust account following any redemptions by
KINS's stockholders; the failure to receive certain governmental
and regulatory approvals; the occurrence of any event, change or
other circumstance that could give rise to the termination of the
merger agreement; changes in general economic conditions, including
as a result of the COVID 19 pandemic or the conflict between
Russia and Ukraine; the outcome of litigation related to
or arising out of the Business Combination, or any adverse
developments therein or delays or costs resulting therefrom; the
effect of the announcement or pendency of the transactions on
Inpixon's, CXApp's or KINS's business relationships, operating
results, and businesses generally; the fluctuation of economic
conditions; the impact of COVID-19, global conflicts, inflation and
other global events on Inpixon's results of operations and global
supply chain constraints; Inpixon's ability to integrate the
products and business from acquisitions into its existing business;
the performance of management and employees; the regulatory
landscape as it relates to privacy regulations and their
applicability to Inpixon's technology; Inpixon's ability to
maintain compliance with Nasdaq's continued listing requirements;
the ability to obtain financing if needed; competition; general
economic conditions; the ability to continue to meet Nasdaq's
listing standards following the consummation of the Business
Combination; costs related to the Business Combination; that the
price of KINS's or Inpixon's securities may be volatile due to a
variety of factors, including Inpixon's, KINS's or CXApp's
inability to implement their business plans or meet or exceed their
financial projections and changes in the combined capital
structure; the ability to implement business plans, forecasts, and
other expectations after the completion of the Business
Combination, and identify and realize additional opportunities; and
the ability of CXApp to implement its strategic initiatives.
The foregoing list of factors is not exhaustive. You should
carefully consider the foregoing factors and the other risks and
uncertainties described in the "Risk Factors" section of Inpixon's
most recent annual report on Form 10-K, KINS's registration
statement on Form S-1 (File No. 333-249177) and the Form S-4, the
Form S-1, the proxy statement/prospectus and certain other
documents filed or that may be filed by Inpixon, KINS or CXApp from
time to time with the SEC following the date hereof. These filings
identify and address other important risks and uncertainties that
could cause actual events and results to differ materially from
those contained in the forward-looking statements. Forward-looking
statements speak only as of the date they are made. Readers are
cautioned not to put undue reliance on forward-looking statements,
and Inpixon, CXApp and KINS assume no obligation and do not intend
to update or revise these forward-looking statements, whether as a
result of new information, future events, or otherwise.
None of Inpixon, CXApp or KINS gives any assurance that Inpixon,
CXApp or KINS will achieve their expectations.
Inpixon Contacts
General inquiries:
Inpixon
Email: marketing@inpixon.com
Web: inpixon.com/contact-us
Investor relations:
Crescendo Communications, LLC
Tel: +1 212-671-1020
Email: INPX@crescendo-ir.com
INPIXON AND
SUBSIDIARIES
|
CONDENSED
CONSOLIDATED BALANCE SHEETS
|
(In thousands,
except number of shares and par value data)
|
|
|
|
|
|
|
|
|
|
As of
|
|
|
September 30,
2022
|
|
|
December 31,
2021
|
|
|
|
|
|
|
(Unaudited)
|
|
(Audited)
|
ASSETS
|
|
|
|
|
Current
Assets
|
|
|
|
|
|
|
Cash and cash
equivalents
|
|
$
|
63,153
|
|
$
|
52,480
|
Accounts receivable,
net of allowances of $268 and $272, respectively
|
|
|
2,879
|
|
|
3,218
|
Other
receivables
|
|
|
137
|
|
|
321
|
Inventory
|
|
|
2,702
|
|
|
1,976
|
Short-term
investments
|
|
|
-
|
|
|
43,125
|
Note
receivable
|
|
|
150
|
|
|
-
|
Prepaid assets and
other current assets
|
|
|
3,258
|
|
|
4,842
|
Total Current
Assets
|
|
|
72,279
|
|
|
105,962
|
|
|
|
|
|
|
|
Property and equipment,
net
|
|
|
1,307
|
|
|
1,442
|
Operating lease
right-of-use asset, net
|
|
|
1,323
|
|
|
1,736
|
Software development
costs, net
|
|
|
1,684
|
|
|
1,792
|
Investment in equity
securities
|
|
|
1,124
|
|
|
1,838
|
Long-term
investments
|
|
|
2,500
|
|
|
2,500
|
Intangible assets,
net
|
|
|
28,174
|
|
|
33,478
|
Goodwill
|
|
|
-
|
|
|
7,672
|
Other assets
|
|
|
204
|
|
|
253
|
Total
Assets
|
|
$
|
108,595
|
|
$
|
156,673
|
|
|
|
|
|
|
|
LIABILITIES AND
STOCKHOLDERS' EQUITY
|
|
|
|
|
|
|
Current
Liabilities
|
|
|
|
|
|
|
Accounts
payable
|
|
$
|
2,559
|
|
$
|
2,414
|
Accrued
liabilities
|
|
|
4,370
|
|
|
10,665
|
Operating lease
obligation, current
|
|
|
514
|
|
|
643
|
Deferred
revenue
|
|
|
3,730
|
|
|
4,805
|
Short-term
debt
|
|
|
6,179
|
|
|
3,490
|
Acquisition
liability
|
|
|
3,376
|
|
|
5,114
|
Total Current
Liabilities
|
|
|
20,728
|
|
|
27,131
|
|
|
|
|
|
|
|
Long Term
Liabilities
|
|
|
|
|
|
|
Operating lease
obligations, noncurrent
|
|
|
852
|
|
|
1,108
|
Other liabilities,
noncurrent
|
|
|
28
|
|
|
28
|
Acquisition liability,
noncurrent
|
|
|
--
|
|
|
220
|
Total
Liabilities
|
|
|
21,608
|
|
|
28,487
|
|
|
|
|
|
|
|
Commitments and
Contingencies
|
|
|
--
|
|
|
--
|
|
|
|
|
|
|
|
Mezzanine
Equity
|
|
|
|
|
|
|
Series 7 Convertible
Preferred Stock - 58,750 shares authorized; zero and 49,250 issued
and outstanding as of September 30, 2022 and December 31, 2021,
respectively.
|
|
|
--
|
|
|
44,695
|
Series 8 Convertible
Preferred Stock - 53,197.7234 shares authorized; 53,197.7234 and
zero issued and outstanding as of September 30, 2022 and December
31, 2021, respectively. (Liquidation preference of
$53,198)
|
|
|
53,198
|
|
|
--
|
|
|
|
|
|
|
|
Stockholders'
Equity
|
|
|
|
|
|
|
Preferred Stock -
$0.001 par value; 5,000,000 shares authorized;
|
|
|
|
|
|
|
Series 4 Convertible
Preferred Stock - 10,415 shares authorized; 1 issued and 1
outstanding as of September 30, 2022 and December 31, 2021,
respectively;
|
|
|
--
|
|
|
--
|
Series 5 Convertible
Preferred Stock - 12,000 shares authorized; 126 issued and 126
outstanding as of September 30, 2022 and December 31, 2021,
respectively.
|
|
|
--
|
|
|
--
|
Common Stock - $0.001
par value; 26,666,667 shares authorized; 2,250,597 and 1,730,141
issued and 2,250,596 and 1,730,140 outstanding as of September 30,
2022 and December 31, 2021, respectively.
|
|
|
2
|
|
|
2
|
Additional paid-in
capital
|
|
|
331,487
|
|
|
332,761
|
Treasury stock, at
cost, 1 share
|
|
|
(695)
|
|
|
(695)
|
Accumulated other
comprehensive income
|
|
|
1,496
|
|
|
44
|
Accumulated
deficit
|
|
|
(299,123)
|
|
|
(250,309)
|
Stockholders' Equity
Attributable to Inpixon
|
|
|
33,167
|
|
|
81,803
|
|
|
|
|
|
|
|
Non-controlling
interest
|
|
|
622
|
|
|
1,688
|
|
|
|
|
|
|
|
Total Stockholders'
Equity
|
|
|
33,789
|
|
|
83,491
|
|
|
|
|
|
|
|
Total Liabilities,
Mezzanine Equity and Stockholders' Equity
|
|
$
|
108,595
|
|
$
|
156,673
|
INPIXON AND
SUBSIDIARIES
|
CONDENSED
CONSOLIDATED STATEMENTS OF OPERATIONS AND COMPREHENSIVE
LOSS
|
(In thousands,
except per share data)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
For the Three Months
Ended,
|
|
For the Nine Months
Ended
|
|
|
September
30,
|
|
September
30,
|
|
|
2022
|
|
2021
|
|
2022
|
|
2021
|
|
|
|
|
|
|
|
|
|
(Unaudited)
|
|
(Unaudited)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Revenues
|
|
$
|
4,177
|
|
$
|
4,450
|
|
$
|
14,133
|
|
$
|
10,857
|
Cost of
Revenues
|
|
|
1,255
|
|
|
1,186
|
|
|
4,037
|
|
|
2,966
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Gross
Profit
|
|
|
2,922
|
|
|
3,264
|
|
|
10,096
|
|
|
7,891
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Operating
Expenses
|
|
|
|
|
|
|
|
|
|
|
|
|
Research and
development
|
|
|
4,644
|
|
|
3,254
|
|
|
13,642
|
|
|
9,185
|
Sales and
marketing
|
|
|
2,157
|
|
|
2,407
|
|
|
6,757
|
|
|
6,119
|
General and
administrative
|
|
|
5,146
|
|
|
8,571
|
|
|
18,148
|
|
|
26,570
|
Acquisition related
costs
|
|
|
2
|
|
|
93
|
|
|
270
|
|
|
1,098
|
Impairment of
goodwill
|
|
|
--
|
|
|
--
|
|
|
7,570
|
|
|
--
|
Amortization of
intangibles
|
|
|
1,366
|
|
|
1,395
|
|
|
4,056
|
|
|
3,088
|
Total Operating
Expenses
|
|
|
13,315
|
|
|
15,720
|
|
|
50,443
|
|
|
46,060
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Loss from
Operations
|
|
|
(10,393)
|
|
|
(12,456)
|
|
|
(40,347)
|
|
|
(38,169)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Other Income
(Expense)
|
|
|
|
|
|
|
|
|
|
|
|
|
Interest
income/(expense), net
|
|
|
(240)
|
|
|
(15)
|
|
|
(62)
|
|
|
1,191
|
Loss on exchange of
debt for equity
|
|
|
--
|
|
|
--
|
|
|
--
|
|
|
(30)
|
Recovery of valuation
allowance on related party loan - held for sale
|
|
|
--
|
|
|
--
|
|
|
--
|
|
|
7,345
|
Other (expense)/income,
net
|
|
|
(1,506)
|
|
|
(47)
|
|
|
(2,277)
|
|
|
464
|
Gain on related party
loan - held for sale
|
|
|
--
|
|
|
--
|
|
|
--
|
|
|
49,817
|
Unrealized gain/(loss)
on equity securities
|
|
|
(5,854)
|
|
|
(22,285)
|
|
|
(7,110)
|
|
|
(51,250)
|
Total Other Income
(Expense)
|
|
|
(7,600)
|
|
|
(22,347)
|
|
|
(9,449)
|
|
|
7,537
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net Loss, before
tax
|
|
|
(17,993)
|
|
|
(34,803)
|
|
|
(49,796)
|
|
|
(30,632)
|
Income tax
benefit/(provision)
|
|
|
--
|
|
|
854
|
|
|
(84)
|
|
|
(1,350)
|
Net
Loss
|
|
|
(17,993)
|
|
|
(33,949)
|
|
|
(49,880)
|
|
|
(31,982)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net Loss
Attributable to Non-controlling Interest
|
|
|
(402)
|
|
|
(309)
|
|
|
(1,206)
|
|
|
(544)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net Loss
Attributable to Stockholders of Inpixon
|
|
$
|
(17,591)
|
|
$
|
(33,640)
|
|
$
|
(48,674)
|
|
$
|
(31,438)
|
Accretion of Series 7
preferred stock
|
|
|
--
|
|
|
(2,962)
|
|
|
(4,555)
|
|
|
(2,962)
|
Accretion of Series 8
Preferred Stock
|
|
|
(6,305)
|
|
|
--
|
|
|
(13,089)
|
|
|
--
|
Deemed dividend for the
modification related to Series 8 Preferred Stock
|
|
|
--
|
|
|
--
|
|
|
(2,627)
|
|
|
--
|
Deemed contribution for
the modification related to Warrants issued in connection with
Series 8 Preferred Stock
|
|
|
--
|
|
|
--
|
|
|
1,469
|
|
|
--
|
Amortization premium-
modification related to Series 8 Prefered Stock
|
|
|
1,265
|
|
|
--
|
|
|
2,626
|
|
|
--
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net Loss
Attributable to Common Stockholders
|
|
$
|
(22,631)
|
|
$
|
(36,602)
|
|
$
|
(64,850)
|
|
$
|
(34,400)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net Loss Per Share -
Basic and Diluted
|
|
$
|
(10.21)
|
|
$
|
(22.31)
|
|
$
|
(31.08)
|
|
$
|
(23.95)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Weighted Average
Shares Outstanding
|
|
|
|
|
|
|
|
|
|
|
|
|
Basic and
Diluted
|
|
|
2,216,544
|
|
|
1,640,971
|
|
|
2,086,633
|
|
|
1,436,093
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Comprehensive
Loss
|
|
|
|
|
|
|
|
|
|
|
|
|
Net Loss
|
|
$
|
(17,993)
|
|
$
|
(33,949)
|
|
$
|
(49,880)
|
|
$
|
(31,982)
|
Unrealized foreign
exchange (loss) income from cumulative translation
adjustments
|
|
|
898
|
|
|
(404)
|
|
|
1,452
|
|
|
(1,012)
|
Comprehensive
Loss
|
|
$
|
(17,095)
|
|
$
|
(34,353)
|
|
$
|
(48,428)
|
|
$
|
(32,994)
|
INPIXON AND
SUBSIDIARIES
|
CONDENSED
CONSOLIDATED STATEMENTS OF CASH FLOWS
|
(In
thousands)
|
|
|
|
|
|
|
|
|
|
For the Nine Months
Ended,
|
|
|
September
30,
|
|
|
2022
|
|
2021
|
(Unaudited)
|
Cash Flows Used In
Operating Activities
|
|
|
|
|
|
|
Net
loss
|
|
$
|
(49,880)
|
|
$
|
(31,982)
|
Adjustments to
reconcile net loss to net cash used in operating
activities:
|
|
|
|
|
|
|
Depreciation and
amortization
|
|
|
1,008
|
|
|
970
|
Amortization of
intangible assets
|
|
|
4,559
|
|
|
3,571
|
Amortization of right
of use asset
|
|
|
536
|
|
|
527
|
Stock based
compensation
|
|
|
2,962
|
|
|
8,813
|
Earnout expense
valuation benefit
|
|
|
(2,827)
|
|
|
--
|
Loss on exchange of
debt for equity
|
|
|
--
|
|
|
30
|
Amortization of debt
discount
|
|
|
--
|
|
|
224
|
Amortization of
original issued discount
|
|
|
121
|
|
|
--
|
Accrued interest
income, related party
|
|
|
(278)
|
|
|
(1,627)
|
Provision for doubtful
accounts
|
|
|
5
|
|
|
100
|
Unrealized gain on
note
|
|
|
1,870
|
|
|
(638)
|
Provision for inventory
obsolescense
|
|
|
--
|
|
|
300
|
Recovery for valuation
allowance held for sale loan
|
|
|
--
|
|
|
(7,345)
|
Gain on settlement of
related party promissory note and loan related party
receivable
|
|
|
--
|
|
|
(49,817)
|
Deferred income
tax
|
|
|
(1)
|
|
|
(4,507)
|
Loss on disposal of
property and equipment
|
|
|
1
|
|
|
--
|
Unrealized loss on
equity securities
|
|
|
7,110
|
|
|
51,250
|
Impairment of
goodwill
|
|
|
7,570
|
|
|
--
|
Realized gain on sale
of equity securities
|
|
|
151
|
|
|
--
|
Gain on conversion of
note receivables
|
|
|
(791)
|
|
|
--
|
Other
|
|
|
196
|
|
|
137
|
|
|
|
|
|
|
|
Changes in operating
assets and liabilities:
|
|
|
|
|
|
|
Accounts receivable and
other receivables
|
|
|
336
|
|
|
(678)
|
Inventory
|
|
|
(1,002)
|
|
|
(499)
|
Prepaid expenses and
other current assets
|
|
|
1,545
|
|
|
(70)
|
Other assets
|
|
|
28
|
|
|
200
|
Accounts
payable
|
|
|
237
|
|
|
(653)
|
Accrued
liabilities
|
|
|
1,059
|
|
|
3,421
|
Income tax
liabilities
|
|
|
(38)
|
|
|
3,471
|
Deferred
revenue
|
|
|
(915)
|
|
|
1,214
|
Operating lease
obligation
|
|
|
(505)
|
|
|
(519)
|
Other
liabilities
|
|
|
--
|
|
|
89
|
Net Cash Used in
Operating Activities
|
|
$
|
(26,943)
|
|
$
|
(24,018)
|
|
|
|
|
|
|
|
Cash Flows Used in
Investing Activities
|
|
|
|
|
|
|
Purchase
of property and equipment
|
|
|
(221)
|
|
|
(258)
|
Investment in
capitalized software
|
|
|
(611)
|
|
|
(857)
|
Purchase of short term
investments
|
|
|
--
|
|
|
(2,000)
|
Sales of short term
investments
|
|
|
--
|
|
|
2,000
|
Purchase of convertible
note
|
|
|
(5,500)
|
|
|
--
|
Sales of equity
securities
|
|
|
229
|
|
|
--
|
Purchases of treasury
bills
|
|
|
--
|
|
|
(63,362)
|
Sales of treasury
bills
|
|
|
43,001
|
|
|
28,000
|
Purchase of Systat
licensing agreement
|
|
|
--
|
|
|
(900)
|
Issuance of note
receivable
|
|
|
(150)
|
|
|
(268)
|
Acquisition of Game
Your Game
|
|
|
--
|
|
|
184
|
Acquisition of
CXApp
|
|
|
--
|
|
|
(15,186)
|
Acquisition of
Visualix
|
|
|
--
|
|
|
(61)
|
Net Cash Provided By
(Used in) Investing Activities
|
|
$
|
36,748
|
|
$
|
(52,708)
|
|
|
|
|
|
|
|
Cash From Financing
Activities
|
|
|
|
|
|
|
Net proceeds from
issuance of preferred stock and warrants
|
|
$
|
46,906
|
|
$
|
50,584
|
Net proceeds from
issuance of common stock and warrants
|
|
|
--
|
|
|
77,853
|
Net proceeds from
promissory note
|
|
|
5,539
|
|
|
--
|
Cash paid for
redemption of preferred stock series 7
|
|
|
(49,250)
|
|
|
--
|
Taxes paid related to
net share settlement of restricted stock units
|
|
|
(336)
|
|
|
(1,687)
|
Loans to related
party
|
|
|
--
|
|
|
(117)
|
Repayment of CXApp
acquisition liability
|
|
|
(1,957)
|
|
|
(241)
|
Repayment of
acquisition liability to Nanotron shareholders
|
|
|
--
|
|
|
(467)
|
Repayment of
acquisition liability to Locality shareholders
|
|
|
--
|
|
|
(500)
|
Net Cash Provided By
Financing Activities
|
|
$
|
902
|
|
$
|
125,425
|
|
|
|
|
|
|
|
Effect of Foreign
Exchange Rate on Changes on Cash
|
|
|
(34)
|
|
|
90
|
|
|
|
|
|
|
|
Net Increase in Cash
and Cash Equivalents
|
|
|
10,673
|
|
|
48,789
|
|
|
|
|
|
|
|
Cash and Cash
Equivalents - Beginning of period
|
|
|
52,480
|
|
|
17,996
|
|
|
|
|
|
|
|
Cash and Cash
Equivalents - End of period
|
|
$
|
63,153
|
|
$
|
66,785
|
Reconciliation of
Non-GAAP Financial Measures:
|
|
|
|
|
|
|
|
|
|
|
|
For the Three Months
Ended
|
|
For the Nines Months
Ended,
|
(In
thousands)
|
|
September
30,
|
|
September
30,
|
|
2022
|
|
2021
|
|
2022
|
|
2021
|
|
|
|
|
|
|
|
|
|
Net loss attributable
to common stockholders
|
|
$
(17,591)
|
|
$
(33,640)
|
|
$
(48,674)
|
|
$
(31,438)
|
Interest
expense/(income), net
|
|
240
|
|
15
|
|
62
|
|
(1,191)
|
Income tax
(benefit)/provision
|
|
-
|
|
(854)
|
|
84
|
|
1,350
|
Depreciation and
amortization
|
|
1,891
|
|
1,903
|
|
5,567
|
|
4,541
|
EBITDA
|
|
(15,460)
|
|
(32,576)
|
|
(42,961)
|
|
(26,738)
|
Adjusted
for:
|
|
|
|
|
|
|
|
|
Non-recurring one-time
charges:
|
|
|
|
|
|
|
|
|
Loss on exchange of
debt for equity
|
|
-
|
|
-
|
|
-
|
|
30
|
Provision for valuation
allowance on held for sale loan
|
|
-
|
|
-
|
|
-
|
|
(7,345)
|
Gain on related party
loan held for sale
|
|
-
|
|
-
|
|
-
|
|
(49,817)
|
Unrealized loss on
equity securities
|
|
5,854
|
|
22,285
|
|
7,110
|
|
51,250
|
Acquisition
transaction/financing costs
|
|
2
|
|
93
|
|
270
|
|
1,098
|
Earnout compensation
expense/(benefit)
|
|
-
|
|
835
|
|
(2,827)
|
|
2,893
|
Professional service fees
|
|
-
|
|
418
|
|
8
|
|
1,189
|
Impairment of goodwill
|
|
-
|
|
-
|
|
7,570
|
|
-
|
Unrealized losses/(gains) on notes, loans,
investments
|
|
-
|
|
(6)
|
|
124
|
|
(497)
|
Bad debts
expense/provision
|
|
5
|
|
100
|
|
5
|
|
100
|
Reserve for inventory
obsolescence
|
|
-
|
|
300
|
|
-
|
|
300
|
Stock-based
compensation – compensation and related benefits
|
|
688
|
|
1,664
|
|
2,962
|
|
8,813
|
Severance
costs
|
|
127
|
|
210
|
|
248
|
|
210
|
Restructuring
Costs
|
|
597
|
|
-
|
|
597
|
|
-
|
Adjusted
EBITDA
|
|
$
(8,187)
|
|
$
(6,677)
|
|
$
(26,894)
|
|
$
(18,514)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
For the Three Months
Ended
|
|
For the Nines Months
Ended,
|
(In thousands, except
share data)
|
|
September
30,
|
|
September
30,
|
|
2022
|
|
2021
|
|
2022
|
|
2021
|
|
|
|
|
|
|
|
|
|
Net loss attributable
to common stockholders
|
|
$
(17,591)
|
|
$
(33,640)
|
|
$
(48,674)
|
|
$
(31,438)
|
Adjustments:
|
|
|
|
|
|
|
|
|
Non-recurring one-time
charges:
|
|
|
|
|
|
|
|
|
Loss on exchange of
debt for equity
|
|
-
|
|
-
|
|
-
|
|
30
|
Provision for valuation
allowance on held for sale loan
|
|
-
|
|
-
|
|
-
|
|
(7,345)
|
Gain on related party
loan held for sale
|
|
-
|
|
-
|
|
-
|
|
(49,817)
|
Unrealized loss on
equity securities
|
|
5,854
|
|
22,285
|
|
7,110
|
|
51,250
|
Acquisition
transaction/financing costs
|
|
2
|
|
93
|
|
270
|
|
1,098
|
Earnout compensation
expense/(benefit)
|
|
-
|
|
835
|
|
(2,827)
|
|
2,893
|
Professional service fees
|
|
-
|
|
418
|
|
8
|
|
1,189
|
Impairment of goodwill
|
|
-
|
|
-
|
|
7,570
|
|
-
|
Unrealized
losses/(gains) on notes, loans, investments
|
|
-
|
|
(6)
|
|
124
|
|
(497)
|
Bad debts
expense/provision
|
|
5
|
|
100
|
|
5
|
|
100
|
Reserve for inventory
obsolescence
|
|
-
|
|
300
|
|
-
|
|
300
|
Stock-based
compensation – compensation and related benefits
|
|
688
|
|
1,664
|
|
2,962
|
|
8,813
|
Severance
costs
|
|
127
|
|
210
|
|
248
|
|
210
|
Restructuring
costs
|
|
597
|
|
-
|
|
597
|
|
-
|
Amortization of
intangibles
|
|
1,533
|
|
1,560
|
|
4,559
|
|
3,571
|
Proforma non-GAAP net
loss
|
|
(8,785)
|
|
(6,181)
|
|
(28,048)
|
|
(19,643)
|
Proforma non-GAAP net
loss per common share - basic and diluted
|
|
$
(3.96)
|
|
$
(3.77)
|
|
$
(13.44)
|
|
$
(13.68)
|
|
|
|
|
|
|
|
|
|
Weighted average basic
and diluted common shares outstanding
|
|
2,216,544
|
|
1,640,971
|
|
2,086,633
|
|
1,436,093
|
View original content to download
multimedia:https://www.prnewswire.com/news-releases/inpixon-reports-third-quarter-2022-financial-results-and-provides-business-update-301677474.html
SOURCE Inpixon